| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.15B | 12.00B | 9.81B | 8.38B | 5.59B | 4.81B |
| Gross Profit | 6.25B | 8.00B | 5.67B | 4.69B | 3.14B | 3.05B |
| EBITDA | -1.42B | 2.05B | -1.75B | 67.00M | 359.00M | 90.00M |
| Net Income | -2.21B | 1.53B | -2.58B | -610.00M | -141.00M | -137.00M |
Balance Sheet | ||||||
| Total Assets | 7.46B | 9.44B | 7.11B | 10.13B | 7.96B | 7.89B |
| Cash, Cash Equivalents and Short-Term Investments | 3.85B | 3.98B | 3.01B | 3.49B | 5.23B | 5.54B |
| Total Debt | 2.48B | 2.23B | 2.55B | 2.85B | 310.00M | 345.22M |
| Total Liabilities | 4.35B | 4.68B | 4.57B | 5.14B | 1.34B | 1.26B |
| Stockholders Equity | 3.02B | 4.64B | 2.46B | 4.93B | 6.54B | 6.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.70B | 505.00M | -1.12B | -843.00M | -445.00M |
| Operating Cash Flow | 0.00 | 1.73B | 621.00M | -197.00M | 71.00M | 24.00M |
| Investing Cash Flow | 0.00 | -1.04B | -880.00M | -2.95B | -483.00M | -701.00M |
| Financing Cash Flow | 0.00 | 285.00M | -221.00M | 1.41B | 105.00M | 3.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥92.91B | 30.95 | ― | ― | 22.27% | ― | |
65 Neutral | ¥14.26B | 50.36 | ― | ― | 26.18% | -33.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥9.84B | 33.78 | ― | ― | 17.58% | -28.24% | |
56 Neutral | ¥4.40B | 7.45 | ― | ― | 21.37% | 30.42% | |
52 Neutral | ¥11.57B | -90.49 | ― | ― | 12.86% | 88.16% | |
45 Neutral | ¥24.56B | 35.20 | ― | ― | 131.28% | 76.67% |